Uroplasty, Vision-Sciences to Merge Into Company Focused on Urology Market

Uroplasty Inc., a Minnesota-based manufacturer of products treating voiding dysfunctions, Dec. 22 announced it would merge with Vision-Sciences Inc. to form Cogentix Medical Inc.

The new company, which will be based in Minnetonka, Minn., will remain focused on the urology market, said Rob Kill, president and chief executive officer of Uroplasty, in a teleconference with investors.

He said the all-stock transaction should be completed in time for the new fiscal year beginning April 1. The merger already has been unanimously approved by the boards of both companies.

Vision-Sciences, which is based in Orangeburg, N.Y., designs, develops, manufactures and markets products ...